Company profile
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Chavant Capital Acquisition Corp.
26 Dec 23
4
Bionik Laboratories Corp.
21 Jun 23
4
Bionik Laboratories Corp.
21 Jun 23
4
Bionik Laboratories Corp.
21 Jun 22
4
Chavant Capital Acquisition Corp.
28 Feb 22
3
Chavant Capital Acquisition Corp.
20 Jul 21
4
Bionik Laboratories Corp.
1 Apr 21
4
Bionik Laboratories Corp.
8 Aug 19
4
Bionik Laboratories Corp.
4 Jun 19
SC 13D/A
Bionik Laboratories Corp.
10 Apr 19
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Dec 23 | Auberton-herve Andre-jacques | Class A Common Stock | Grant | Acquire A | Yes | No | 0 | 198,049 | 0.00 | 540,966 |
21 Dec 23 | Auberton-herve Andre-jacques | Class A Common Stock | Grant | Acquire A | Yes | No | 10 | 145,335 | 1.45 mm | 342,917 |
21 Dec 23 | Auberton-herve Andre-jacques | Make-Whole Shares (right to acquire) Class A Common Stock | Grant | Acquire A | Yes | No | 10 | 145,335 | 1.45 mm | 145,335 |
13 Jun 23 | Auberton-herve Andre-jacques | Common Stock | Conversion | Acquire C | Yes | No | 0.6 | 186,111 | 111.67 k | 1,109,271 |
13 Jun 23 | Auberton-herve Andre-jacques | Convertible Promissory Note Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 220000 | 1 | 220.00 k | 1 |
9 Jun 23 | Auberton-herve Andre-jacques | Common Stock | Buy | Acquire P | Yes | No | 0.6 | 650,000 | 390.00 k | 923,160 |